Status: Recruiting
A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics
This study will take place at multiple sites and is divided into three phases:an initial 4-week getting-to-know-you phase,a 26-week main phase where participants receive medication,and a 4-week follow-up phase.Participants will be divided into three groups:two will receive different doses of PEG-rhGH Injection,and the third will receive hGH Injection.The goal is to determine which medication works best.
Participants needed: 72
Trial details
Phase: Phase 2Age: 3+Biological sex: AllType: InterventionalSponsor: Changchun GeneScience Pharmaceutical Co., Ltd.Updated: Feb 17, 2026Locations: 1
Eligibility criteria
Born full-term and "small-for-dates" - Born at 37-41 weeks (full-term). - Birth... [+6]
Severe allergy to growth hormone or its ingredients. [+14]